Dyadic International (NASDAQ: DYAI) — Perfil da empresa, notícias e dados financeiros
Dyadic International specializes in developing biologic products using its proprietary C1-cell protein production platform.

Dyadic International
Dyadic International (NASDAQ:DYAI) is a biotechnology company focused on developing, manufacturing, and commercializing a wide range of biologic products. Utilizing its proprietary C1-cell protein production platform, Dyadic aims to create efficient and cost-effective biopharmaceuticals for industrial, animal, and human health applications. Projects include developing vaccines, monoclonal antibodies, and other therapeutic proteins. Dyadic's ultimate objective is to improve health standards globally by making biologic vaccines and drugs more accessible and affordable to healthcare systems and patients around the world.
Resumo
Operações
Produtos e/ou serviços de Dyadic International
- C1 Protein Production Platform - A proprietary biotechnology platform for developing and producing low-cost, high-performance biological products.
- Biopharmaceuticals Development - Focused on developing and licensing recombinant proteins and antibodies for human health applications.
- Industrial Enzymes - Creating and optimizing enzymes for use in industrial processes, including biofuels, paper, and textiles.
- Animal Health Solutions - Developing vaccines and antibodies for livestock protection and productivity enhancement.
- Biosecurity - Working on solutions for preventing and controlling infectious diseases in crops and livestock.
- Research Partnerships - Collaborating with pharmaceutical and biotechnology companies, academic institutions, and government agencies for biotech advancements.
equipe executiva do Dyadic International
- Mark A. EmalfarbFounder, CEO & Director
- Joseph P. HazeltonPresident & COO
- Ping Wang RawsonCFO & Principal Accounting Officer
- Ana Gómez RodriguezSecretary of the Board
Últimas notícias sobre a Dyadic International
Comunicados recentes
O que a Dyadic International (DYAI) comunicou ao mercado, do mais recente para o mais antigo.
Principais indicadores financeiros
Resultados divulgados pela Dyadic International, em USD.
- Cap. de mercado
- 12,8 mi
- Receita (TTM)
- 3,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.2
- Dividend yield
- —
- Margem de lucro
- -200.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,2 mi | -7,1 mi | -7,4 mi | |
| 3,5 mi | -5,9 mi | -5,8 mi | |
| 2,9 mi | -8,2 mi | -6,8 mi | |
| 2,9 mi | -10,2 mi | -9,7 mi |